Drug intelligence / Profile preview

Neutrogena Rapid Clear

Development stage
Unknown
Lead developer
Kenvue
Modality
Small Molecules
Administration
Topical
01

Overview

Neutrogena Rapid Clear is a topical over-the-counter acne treatment product containing 2% salicylic acid. As a beta-hydroxy acid (BHA), salicylic acid acts as a keratolytic and comedolytic agent by promoting the exfoliation of dead skin cells and penetrating into pores to dissolve sebum and cellular debris. This specific product was utilized as a commercial active comparator in a clinical study sponsored by GlaxoSmithKline (GSK) to evaluate the speed of efficacy of a 3% benzoyl peroxide gel in reducing the swelling and redness of acne vulgaris lesions over a five-day period. While Neutrogena is a brand of Johnson & Johnson, the product's inclusion in GSK's clinical research highlights its role as a standard-of-care reference for rapid-acting acne treatments.

Brand names
Neutrogena Rapid Clear
Other names
salicylic acid

Beyond the preview

Go deeper on Neutrogena Rapid Clear.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrogena Rapid Clear.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call